Device type · NVY
Permanent Defibrillator Electrodes
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
NVY
Cardiovascular
Device class
Class III
FDA decisions since 2015
1
510(k), De Novo and PMA
Adverse event reports
11,395
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Permanent Defibrillator Electrodes
- Product code
- NVY
- Device class
- Class III
- Review panel
- Cardiovascular
- Specialty
- Cardiology, Electrophysiology
- FDA record
- Classification database entry for NVY
Latest FDA decisions
- OmniaSecure MRI SureScan Lead Model 3930MBreakthroughPMA
P240036 · Decided Apr 22, 2025 · 186 days after receipt
Device type: Permanent defibrillator electrodes (NVY) · Cardiology
Reports received
11,395
Received Nov 1, 2025 to Nov 19, 2026. Includes 83 of another or unstated type.
Malfunction reports
5,156
45% of reports
Injury reports
6,052
53% of reports
Death reports
104
0.9% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 292 | 310 | 4 | 0 |
| Jan 24 | 361 | 373 | 8 | 0 |
| Feb 24 | 341 | 376 | 9 | 0 |
| Mar 24 | 383 | 384 | 8 | 0 |
| Apr 24 | 323 | 413 | 8 | 0 |
| May 24 | 363 | 364 | 8 | 2 |
| Jun 24 | 353 | 374 | 5 | 0 |
| Jul 24 | 358 | 436 | 5 | 0 |
| Aug 24 | 379 | 425 | 8 | 0 |
| Sep 24 | 317 | 415 | 6 | 0 |
| Oct 24 | 414 | 519 | 4 | 1 |
| Nov 24 | 307 | 487 | 5 | 0 |
| Dec 24 | 354 | 463 | 3 | 0 |
| Jan 25 | 419 | 445 | 11 | 1 |
| Feb 25 | 344 | 424 | 3 | 1 |
| Mar 25 | 395 | 464 | 10 | 0 |
| Apr 25 | 469 | 485 | 14 | 1 |
| May 25 | 390 | 436 | 8 | 0 |
| Jun 25 | 359 | 469 | 6 | 2 |
| Jul 25 | 1,070 | 579 | 13 | 0 |
| Aug 25 | 671 | 450 | 9 | 1 |
| Sep 25 | 434 | 446 | 5 | 1 |
| Oct 25 | 468 | 501 | 8 | 0 |
| Nov 25 | 439 | 440 | 9 | 0 |
| Dec 25 | 458 | 474 | 10 | 0 |
| Jan 26 | 377 | 462 | 7 | 0 |
| Feb 26 | 458 | 498 | 10 | 0 |
| Mar 26 | 439 | 604 | 10 | 0 |
| Apr 26 | 419 | 517 | 8 | 2 |
| May 26 | 383 | 509 | 15 | 0 |
| Jun 26 | 502 | 556 | 11 | 0 |
| Jul 26 | 428 | 501 | 5 | 0 |
| Aug 26 | 392 | 450 | 7 | 3 |
| Sep 26 | 435 | 524 | 7 | 27 |
| Oct 26 | 426 | 517 | 5 | 51 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Boston Scientific3,527
- Abbott3,291
- Medtronic2,753
- Biotronik Se & Kg1,690
- Unk2
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Over-Sensing2,919
- High impedance2,730
- Adverse Event Without Identified Device or Use Problem1,719
- Signal Artifact/Noise1,178
- Device Dislodged or Dislocated1,019
- Inappropriate/Inadequate Shock/Stimulation750
- Failure to Capture749
- High Capture Threshold614
- Fracture587
- Low impedance545
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions8,202
- Unspecified Infection1,392
- Shock from Patient Lead(s)611
- Insufficient Information276
- Discomfort198
- Cardiac Perforation133
- Arrhythmia89
- Syncope/Fainting76
- Pocket Erosion73
- Ventricular Fibrillation69
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0285-2027 · Started Sep 17, 2026 · Posted by FDA Oct 23, 2026
Reason given: Affected leads require additional engineering evaluation due to complaints regarding difficulty in achieving fixation during implantation. Potential harm of tissue trauma due to implant difficulty.
Cause as FDA categorized it: Process design
Z-2326-2025 · Started Jul 24, 2025 · Posted by FDA Aug 20, 2025
Reason given: Affected lead models may experience gradually rising LVSI measurements in association with calcification of the defibrillation lead coils. The issue may lead to early lead replacement. Most serious harm is death or need for cardiac resuscitation.
Cause as FDA categorized it: Component design/selection
Z-2327-2025 · Started Jul 24, 2025 · Posted by FDA Aug 20, 2025
Reason given: Affected lead models may experience gradually rising LVSI measurements in association with calcification of the defibrillation lead coils. The issue may lead to early lead replacement. Most serious harm is death or need for cardiac resuscitation.
Cause as FDA categorized it: Component design/selection
Z-0151-2023 · Started Sep 30, 2022 · Posted by FDA Oct 31, 2022
Reason given: There is an incorrect manufacturing date/timestamp within the software which causes an inaccurate display of battery capacity.
Cause as FDA categorized it: Under Investigation by firm
Z-0152-2023 · Started Sep 30, 2022 · Posted by FDA Oct 31, 2022
Reason given: There is an incorrect manufacturing date/timestamp within the software which causes an inaccurate display of battery capacity.
Cause as FDA categorized it: Under Investigation by firm
- Medical Device Identification Cards associated with Sprint Quattro Lead, Product/CFN 6935M72Terminated
Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
Z-0390-2022 · Started Nov 8, 2021
Reason given: The back of some Medical Device Identification Cards provided to patients were printed with an erroneous statement stating the following: "This patient has a complete MR conditional system implanted."
Cause as FDA categorized it: Error in labeling
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.